Bipolar disorder affects approximately 1% of the population and is characterized by alternating episodes of depression, mania, or hypomania. This paper examines the multifactorial etiology of bipolar disorder, including genetic influences (accounting for 60–80% of risk), physiological abnormalities in brain structure and function, environmental stressors, neurological conditions, and neurotransmitter dysfunction. The paper discusses how dopamine, glutamate, and GABA dysregulation contribute to mood cycling, explores diagnostic challenges due to symptom overlap with other psychiatric disorders, and reviews available pharmacological treatments including anticonvulsants, antipsychotics, and lithium. Despite extensive research, no single cause has been identified, and treatment remains symptom-focused rather than curative.
Bipolar disorder is characterized by transitions between depression and mania or hypomania, depending on severity. Individuals who experience manic episodes also experience depressive episodes or symptoms, or mixed episodes in which both mania and depression are present simultaneously. These episodes are usually separated by periods of normal mood, but in some individuals, depression and mania may rapidly alternate, a condition known as rapid cycling.
Over 3 million Americans, approximately 1% of the population (or 1 in every 100 people), suffer from bipolar disorder, with similar rates reported in other countries. Bipolar disorder occurs equally among males and females, and often begins between the ages of 15 and 24. While the exact cause of this disorder remains unclear, several factors are known to contribute to its development, including genetic, physiological, environmental, neurological, and neuroendocrinological influences.
Genetic influences are believed to account for 60 to 80% of the risk for developing bipolar disorder. Although scientists have been unable to pinpoint a specific gene responsible for the disorder, their findings have concluded that variants within the genes CACNA1C, ODZ4, and NCAN can be major factors in its development. An increase in these genetic mutations has been linked to advanced paternal age, leading to an increased risk of bipolar disorder development in offspring (Kerner 2014).
Physiological influences, including abnormalities in the structure and function of certain brain circuits, play a major role in the development of bipolar disorder. Brain imaging studies have demonstrated an increase in the volume of the lateral ventricles, globus pallidus, and rates of deep white matter hyperintensities. These studies also suggest that abnormal modulation between the ventral prefrontal and limbic regions, including the amygdala, contributes to poor emotional regulation and mood instabilities (Goodwin & Jamison 2007).
Alterations to mitochondrial function and the sodium ATPase pump are also believed to cause poor neuron firing and hypersensitive neuron firing, resulting in periods of depression and mania. These cellular-level dysfunctions provide a mechanistic explanation for the observable mood fluctuations characteristic of bipolar disorder.
Scientific evidence also suggests that environmental factors combined with physiological abnormalities in people genetically predisposed for bipolar disorder raise the risk factor significantly. Thirty to 50% of adults diagnosed with bipolar disorder report traumatic experiences during childhood. "There is evidence supporting an association between early-life stress and dysfunction of the hypothalamic-pituitary-adrenal axis (HPA axis) leading to its over-activation, which may play a role in the pathogenesis of bipolar disorder" (Sedler 2010).
Neurological conditions or injuries, though less common, have also been known to lead to bipolar disorder development. These conditions include temporal lobe epilepsy, stroke, brain injury, multiple sclerosis, porphyria, and HIV infection. Though these conditions or injuries are less likely to cause bipolar disorder, the disorder can develop over time depending on the severity of the damage and the brain area affected by the trauma.
Scientists have determined that three neurotransmitters are involved in bipolar disorder: dopamine, glutamate, and gamma-aminobutyric acid (GABA). Dopamine is responsible for mood regulation and has increased transmission during the manic phase. "The dopamine hypothesis states that the increase in dopamine results in secondary homeostatic down-regulation of key systems and receptors such as an increase in dopamine-mediated G protein-coupled receptors" (Sedler 2010). This decrease in dopamine transmission causes the depressive phase, and when the depressive phase ends, the cycle starts over again.
"Trauma, HPA axis dysfunction, and acquired conditions"
Bowins B. (2007). "Cognitive regulatory control therapies". American Journal of Psychotherapy 67(3): 215–36.
Goodwin, F. K.; Jamison, K. R. (2007). Manic-depressive illness: Bipolar disorders and recurrent depression (2nd ed.). Oxford University Press.
Kerner B. (2014). "Genetics of bipolar disorder". Applied Clinical Genetics 7: 33–42.
Muneer A. (2013). "Treatment of the depressive phase of bipolar affective disorder: A review". Journal of the Pakistan Medical Association 63(6): 763–9.
"Diagnostic challenges and available pharmacological interventions"
You’re 68% through this paper. Sign up to read the remaining 2 sections.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.